nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—ovarian cancer	0.63	1	CbGaD
Scopolamine—ABCB1—Topotecan—ovarian cancer	0.0583	0.354	CbGbCtD
Scopolamine—ABCB1—Vinorelbine—ovarian cancer	0.0411	0.249	CbGbCtD
Scopolamine—ABCB1—Paclitaxel—ovarian cancer	0.0289	0.175	CbGbCtD
Scopolamine—ABCB1—Docetaxel—ovarian cancer	0.0209	0.127	CbGbCtD
Scopolamine—CHRM3—muscle of abdomen—ovarian cancer	0.0172	0.272	CbGeAlD
Scopolamine—ABCB1—Doxorubicin—ovarian cancer	0.0156	0.0945	CbGbCtD
Scopolamine—SI—embryo—ovarian cancer	0.0116	0.184	CbGeAlD
Scopolamine—SI—female reproductive system—ovarian cancer	0.00706	0.111	CbGeAlD
Scopolamine—SI—testis—ovarian cancer	0.0057	0.0899	CbGeAlD
Scopolamine—CHRM5—epithelium—ovarian cancer	0.00367	0.0579	CbGeAlD
Scopolamine—CHRM4—testis—ovarian cancer	0.00281	0.0444	CbGeAlD
Scopolamine—CHRM1—female reproductive system—ovarian cancer	0.0017	0.0269	CbGeAlD
Scopolamine—CHRM3—female reproductive system—ovarian cancer	0.00152	0.024	CbGeAlD
Scopolamine—CHRM3—female gonad—ovarian cancer	0.00139	0.0219	CbGeAlD
Scopolamine—Hallucination—Chlorambucil—ovarian cancer	0.00123	0.00867	CcSEcCtD
Scopolamine—CHRM3—testis—ovarian cancer	0.00123	0.0194	CbGeAlD
Scopolamine—Muscular weakness—Vinorelbine—ovarian cancer	0.0012	0.00846	CcSEcCtD
Scopolamine—Dysphagia—Vinorelbine—ovarian cancer	0.00118	0.00829	CcSEcCtD
Scopolamine—Sweating—Topotecan—ovarian cancer	0.00118	0.00828	CcSEcCtD
Scopolamine—Dry eye—Paclitaxel—ovarian cancer	0.00117	0.00821	CcSEcCtD
Scopolamine—Pharyngitis—Topotecan—ovarian cancer	0.00109	0.0077	CcSEcCtD
Scopolamine—Redness—Epirubicin—ovarian cancer	0.00107	0.00753	CcSEcCtD
Scopolamine—Urinary tract disorder—Melphalan—ovarian cancer	0.00107	0.0075	CcSEcCtD
Scopolamine—Urethral disorder—Melphalan—ovarian cancer	0.00106	0.00745	CcSEcCtD
Scopolamine—ABCB1—myometrium—ovarian cancer	0.00102	0.016	CbGeAlD
Scopolamine—Tremor—Chlorambucil—ovarian cancer	0.00101	0.00711	CcSEcCtD
Scopolamine—Flushing—Melphalan—ovarian cancer	0.001	0.00705	CcSEcCtD
Scopolamine—Agitation—Chlorambucil—ovarian cancer	0.00099	0.00697	CcSEcCtD
Scopolamine—Redness—Doxorubicin—ovarian cancer	0.000989	0.00696	CcSEcCtD
Scopolamine—ABCB1—embryo—ovarian cancer	0.000978	0.0154	CbGeAlD
Scopolamine—Arrhythmia—Melphalan—ovarian cancer	0.000963	0.00678	CcSEcCtD
Scopolamine—Amblyopia—Epirubicin—ovarian cancer	0.000934	0.00658	CcSEcCtD
Scopolamine—Confusional state—Chlorambucil—ovarian cancer	0.000886	0.00624	CcSEcCtD
Scopolamine—Flushing—Vinorelbine—ovarian cancer	0.000874	0.00616	CcSEcCtD
Scopolamine—Amblyopia—Doxorubicin—ovarian cancer	0.000865	0.00609	CcSEcCtD
Scopolamine—Arrhythmia—Vinorelbine—ovarian cancer	0.000842	0.00593	CcSEcCtD
Scopolamine—Dry skin—Paclitaxel—ovarian cancer	0.00084	0.00591	CcSEcCtD
Scopolamine—Erythema—Vinorelbine—ovarian cancer	0.00082	0.00578	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000811	0.00571	CcSEcCtD
Scopolamine—Muscular weakness—Paclitaxel—ovarian cancer	0.000808	0.00569	CcSEcCtD
Scopolamine—ABCB1—epithelium—ovarian cancer	0.000798	0.0126	CbGeAlD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000794	0.00559	CcSEcCtD
Scopolamine—Dysphagia—Paclitaxel—ovarian cancer	0.000792	0.00558	CcSEcCtD
Scopolamine—ABCB1—uterine cervix—ovarian cancer	0.000791	0.0125	CbGeAlD
Scopolamine—Nervous system disorder—Topotecan—ovarian cancer	0.000767	0.0054	CcSEcCtD
Scopolamine—Oedema—Melphalan—ovarian cancer	0.000766	0.0054	CcSEcCtD
Scopolamine—Skin disorder—Topotecan—ovarian cancer	0.00076	0.00535	CcSEcCtD
Scopolamine—Fatigue—Chlorambucil—ovarian cancer	0.000758	0.00534	CcSEcCtD
Scopolamine—Hyperhidrosis—Topotecan—ovarian cancer	0.000757	0.00533	CcSEcCtD
Scopolamine—ABCB1—decidua—ovarian cancer	0.000754	0.0119	CbGeAlD
Scopolamine—Pain—Chlorambucil—ovarian cancer	0.000752	0.00529	CcSEcCtD
Scopolamine—Tachycardia—Melphalan—ovarian cancer	0.000748	0.00527	CcSEcCtD
Scopolamine—Skin disorder—Melphalan—ovarian cancer	0.000744	0.00524	CcSEcCtD
Scopolamine—Dysuria—Paclitaxel—ovarian cancer	0.00074	0.00521	CcSEcCtD
Scopolamine—Vertigo—Vinorelbine—ovarian cancer	0.000737	0.00519	CcSEcCtD
Scopolamine—Feeling abnormal—Chlorambucil—ovarian cancer	0.000724	0.0051	CcSEcCtD
Scopolamine—Hypotension—Melphalan—ovarian cancer	0.000716	0.00504	CcSEcCtD
Scopolamine—ABCB1—endometrium—ovarian cancer	0.000715	0.0113	CbGeAlD
Scopolamine—Dry skin—Docetaxel—ovarian cancer	0.000712	0.00501	CcSEcCtD
Scopolamine—Body temperature increased—Chlorambucil—ovarian cancer	0.000695	0.00489	CcSEcCtD
Scopolamine—Abdominal pain—Chlorambucil—ovarian cancer	0.000695	0.00489	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000694	0.00488	CcSEcCtD
Scopolamine—Conjunctivitis—Paclitaxel—ovarian cancer	0.000686	0.00483	CcSEcCtD
Scopolamine—Fatigue—Topotecan—ovarian cancer	0.000675	0.00475	CcSEcCtD
Scopolamine—Dysphagia—Docetaxel—ovarian cancer	0.000671	0.00473	CcSEcCtD
Scopolamine—Constipation—Topotecan—ovarian cancer	0.000669	0.00471	CcSEcCtD
Scopolamine—Pain—Topotecan—ovarian cancer	0.000669	0.00471	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—ovarian cancer	0.000666	0.00469	CcSEcCtD
Scopolamine—ABCB1—gonad—ovarian cancer	0.000664	0.0105	CbGeAlD
Scopolamine—Fatigue—Melphalan—ovarian cancer	0.000661	0.00465	CcSEcCtD
Scopolamine—ABCB1—uterus—ovarian cancer	0.000659	0.0104	CbGeAlD
Scopolamine—Nervous system disorder—Vinorelbine—ovarian cancer	0.000657	0.00462	CcSEcCtD
Scopolamine—Pain—Melphalan—ovarian cancer	0.000655	0.00461	CcSEcCtD
Scopolamine—Tachycardia—Vinorelbine—ovarian cancer	0.000653	0.0046	CcSEcCtD
Scopolamine—Skin disorder—Vinorelbine—ovarian cancer	0.00065	0.00458	CcSEcCtD
Scopolamine—Bradycardia—Paclitaxel—ovarian cancer	0.000645	0.00454	CcSEcCtD
Scopolamine—Feeling abnormal—Topotecan—ovarian cancer	0.000645	0.00454	CcSEcCtD
Scopolamine—Asthenia—Chlorambucil—ovarian cancer	0.000631	0.00444	CcSEcCtD
Scopolamine—Pharyngitis—Paclitaxel—ovarian cancer	0.000629	0.00443	CcSEcCtD
Scopolamine—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000626	0.00441	CcSEcCtD
Scopolamine—Hypotension—Vinorelbine—ovarian cancer	0.000626	0.00441	CcSEcCtD
Scopolamine—Pruritus—Chlorambucil—ovarian cancer	0.000622	0.00438	CcSEcCtD
Scopolamine—Urethral disorder—Paclitaxel—ovarian cancer	0.000621	0.00438	CcSEcCtD
Scopolamine—Abdominal pain—Topotecan—ovarian cancer	0.000619	0.00436	CcSEcCtD
Scopolamine—Body temperature increased—Topotecan—ovarian cancer	0.000619	0.00436	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—ovarian cancer	0.000617	0.00434	CcSEcCtD
Scopolamine—Visual impairment—Paclitaxel—ovarian cancer	0.000611	0.0043	CcSEcCtD
Scopolamine—ABCB1—female reproductive system—ovarian cancer	0.000593	0.00935	CbGeAlD
Scopolamine—Eye disorder—Paclitaxel—ovarian cancer	0.000592	0.00417	CcSEcCtD
Scopolamine—Flushing—Paclitaxel—ovarian cancer	0.000588	0.00414	CcSEcCtD
Scopolamine—Eczema—Epirubicin—ovarian cancer	0.000583	0.0041	CcSEcCtD
Scopolamine—Conjunctivitis—Docetaxel—ovarian cancer	0.000582	0.0041	CcSEcCtD
Scopolamine—Fatigue—Vinorelbine—ovarian cancer	0.000577	0.00406	CcSEcCtD
Scopolamine—Pain—Vinorelbine—ovarian cancer	0.000572	0.00403	CcSEcCtD
Scopolamine—Constipation—Vinorelbine—ovarian cancer	0.000572	0.00403	CcSEcCtD
Scopolamine—Arrhythmia—Paclitaxel—ovarian cancer	0.000566	0.00399	CcSEcCtD
Scopolamine—Asthenia—Topotecan—ovarian cancer	0.000561	0.00395	CcSEcCtD
Scopolamine—ABCB1—bone marrow—ovarian cancer	0.00056	0.00883	CbGeAlD
Scopolamine—Vomiting—Chlorambucil—ovarian cancer	0.000559	0.00394	CcSEcCtD
Scopolamine—Mental disorder—Paclitaxel—ovarian cancer	0.000555	0.00391	CcSEcCtD
Scopolamine—Pruritus—Topotecan—ovarian cancer	0.000554	0.0039	CcSEcCtD
Scopolamine—Erythema—Paclitaxel—ovarian cancer	0.000552	0.00389	CcSEcCtD
Scopolamine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000552	0.00388	CcSEcCtD
Scopolamine—Asthenia—Melphalan—ovarian cancer	0.00055	0.00387	CcSEcCtD
Scopolamine—Pruritus—Melphalan—ovarian cancer	0.000542	0.00382	CcSEcCtD
Scopolamine—ABCB1—female gonad—ovarian cancer	0.000539	0.00851	CbGeAlD
Scopolamine—Eczema—Doxorubicin—ovarian cancer	0.000539	0.0038	CcSEcCtD
Scopolamine—ABCB1—vagina—ovarian cancer	0.000536	0.00846	CbGeAlD
Scopolamine—Pharyngitis—Docetaxel—ovarian cancer	0.000533	0.00375	CcSEcCtD
Scopolamine—Urinary tract disorder—Docetaxel—ovarian cancer	0.000531	0.00374	CcSEcCtD
Scopolamine—Abdominal pain—Vinorelbine—ovarian cancer	0.000529	0.00373	CcSEcCtD
Scopolamine—Body temperature increased—Vinorelbine—ovarian cancer	0.000529	0.00373	CcSEcCtD
Scopolamine—Urethral disorder—Docetaxel—ovarian cancer	0.000527	0.00371	CcSEcCtD
Scopolamine—Nausea—Chlorambucil—ovarian cancer	0.000522	0.00368	CcSEcCtD
Scopolamine—Vision blurred—Paclitaxel—ovarian cancer	0.00052	0.00366	CcSEcCtD
Scopolamine—Visual impairment—Docetaxel—ovarian cancer	0.000518	0.00365	CcSEcCtD
Scopolamine—Dizziness—Topotecan—ovarian cancer	0.000517	0.00364	CcSEcCtD
Scopolamine—Tremor—Paclitaxel—ovarian cancer	0.000517	0.00364	CcSEcCtD
Scopolamine—Agitation—Paclitaxel—ovarian cancer	0.000507	0.00357	CcSEcCtD
Scopolamine—Eye disorder—Docetaxel—ovarian cancer	0.000502	0.00354	CcSEcCtD
Scopolamine—Flushing—Docetaxel—ovarian cancer	0.000499	0.00351	CcSEcCtD
Scopolamine—Vomiting—Topotecan—ovarian cancer	0.000498	0.0035	CcSEcCtD
Scopolamine—Vertigo—Paclitaxel—ovarian cancer	0.000496	0.00349	CcSEcCtD
Scopolamine—Rash—Topotecan—ovarian cancer	0.000493	0.00347	CcSEcCtD
Scopolamine—Dermatitis—Topotecan—ovarian cancer	0.000493	0.00347	CcSEcCtD
Scopolamine—Headache—Topotecan—ovarian cancer	0.00049	0.00345	CcSEcCtD
Scopolamine—Vomiting—Melphalan—ovarian cancer	0.000487	0.00343	CcSEcCtD
Scopolamine—Rash—Melphalan—ovarian cancer	0.000483	0.0034	CcSEcCtD
Scopolamine—Dermatitis—Melphalan—ovarian cancer	0.000483	0.0034	CcSEcCtD
Scopolamine—Asthenia—Vinorelbine—ovarian cancer	0.00048	0.00338	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—ovarian cancer	0.00048	0.00338	CcSEcCtD
Scopolamine—Arrhythmia—Docetaxel—ovarian cancer	0.00048	0.00338	CcSEcCtD
Scopolamine—ABCB1—testis—ovarian cancer	0.000478	0.00755	CbGeAlD
Scopolamine—Pruritus—Vinorelbine—ovarian cancer	0.000474	0.00334	CcSEcCtD
Scopolamine—Mental disorder—Docetaxel—ovarian cancer	0.000471	0.00331	CcSEcCtD
Scopolamine—Erythema—Docetaxel—ovarian cancer	0.000468	0.00329	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000466	0.00328	CcSEcCtD
Scopolamine—Nausea—Topotecan—ovarian cancer	0.000465	0.00327	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—ovarian cancer	0.000462	0.00325	CcSEcCtD
Scopolamine—Dry mouth—Paclitaxel—ovarian cancer	0.000459	0.00323	CcSEcCtD
Scopolamine—Nausea—Melphalan—ovarian cancer	0.000455	0.00321	CcSEcCtD
Scopolamine—Confusional state—Paclitaxel—ovarian cancer	0.000454	0.0032	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—ovarian cancer	0.000453	0.00319	CcSEcCtD
Scopolamine—Oedema—Paclitaxel—ovarian cancer	0.00045	0.00317	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—ovarian cancer	0.000444	0.00313	CcSEcCtD
Scopolamine—Dizziness—Vinorelbine—ovarian cancer	0.000443	0.00312	CcSEcCtD
Scopolamine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000442	0.00311	CcSEcCtD
Scopolamine—Tachycardia—Paclitaxel—ovarian cancer	0.000439	0.00309	CcSEcCtD
Scopolamine—Skin disorder—Paclitaxel—ovarian cancer	0.000437	0.00308	CcSEcCtD
Scopolamine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000435	0.00307	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—ovarian cancer	0.000427	0.00301	CcSEcCtD
Scopolamine—Vomiting—Vinorelbine—ovarian cancer	0.000426	0.003	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—ovarian cancer	0.000423	0.00298	CcSEcCtD
Scopolamine—Rash—Vinorelbine—ovarian cancer	0.000422	0.00297	CcSEcCtD
Scopolamine—Dermatitis—Vinorelbine—ovarian cancer	0.000422	0.00297	CcSEcCtD
Scopolamine—Hypotension—Paclitaxel—ovarian cancer	0.000421	0.00296	CcSEcCtD
Scopolamine—Headache—Vinorelbine—ovarian cancer	0.000419	0.00295	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—ovarian cancer	0.000419	0.00295	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—ovarian cancer	0.000404	0.00284	CcSEcCtD
Scopolamine—Somnolence—Paclitaxel—ovarian cancer	0.0004	0.00282	CcSEcCtD
Scopolamine—Nausea—Vinorelbine—ovarian cancer	0.000398	0.0028	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000395	0.00278	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—ovarian cancer	0.000392	0.00276	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—ovarian cancer	0.000392	0.00276	CcSEcCtD
Scopolamine—Dry mouth—Docetaxel—ovarian cancer	0.000389	0.00274	CcSEcCtD
Scopolamine—Fatigue—Paclitaxel—ovarian cancer	0.000388	0.00273	CcSEcCtD
Scopolamine—Sweating—Epirubicin—ovarian cancer	0.000387	0.00272	CcSEcCtD
Scopolamine—Pain—Paclitaxel—ovarian cancer	0.000385	0.00271	CcSEcCtD
Scopolamine—Constipation—Paclitaxel—ovarian cancer	0.000385	0.00271	CcSEcCtD
Scopolamine—Confusional state—Docetaxel—ovarian cancer	0.000385	0.00271	CcSEcCtD
Scopolamine—Oedema—Docetaxel—ovarian cancer	0.000382	0.00269	CcSEcCtD
Scopolamine—Nervous system disorder—Docetaxel—ovarian cancer	0.000374	0.00264	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—ovarian cancer	0.000373	0.00263	CcSEcCtD
Scopolamine—Tachycardia—Docetaxel—ovarian cancer	0.000372	0.00262	CcSEcCtD
Scopolamine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000371	0.00261	CcSEcCtD
Scopolamine—Skin disorder—Docetaxel—ovarian cancer	0.000371	0.00261	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—ovarian cancer	0.000369	0.0026	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000363	0.00256	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—ovarian cancer	0.00036	0.00253	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—ovarian cancer	0.000358	0.00252	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000358	0.00252	CcSEcCtD
Scopolamine—Hypotension—Docetaxel—ovarian cancer	0.000357	0.00251	CcSEcCtD
Scopolamine—Abdominal pain—Paclitaxel—ovarian cancer	0.000356	0.00251	CcSEcCtD
Scopolamine—Body temperature increased—Paclitaxel—ovarian cancer	0.000356	0.00251	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—ovarian cancer	0.000355	0.0025	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—ovarian cancer	0.000349	0.00246	CcSEcCtD
Scopolamine—ABCB1—lymph node—ovarian cancer	0.000347	0.00547	CbGeAlD
Scopolamine—Bradycardia—Doxorubicin—ovarian cancer	0.000341	0.0024	CcSEcCtD
Scopolamine—Somnolence—Docetaxel—ovarian cancer	0.000339	0.00239	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—ovarian cancer	0.000339	0.00238	CcSEcCtD
Scopolamine—Flushing—Epirubicin—ovarian cancer	0.000336	0.00237	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—ovarian cancer	0.000333	0.00234	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000331	0.00233	CcSEcCtD
Scopolamine—Fatigue—Docetaxel—ovarian cancer	0.000329	0.00232	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—ovarian cancer	0.000329	0.00231	CcSEcCtD
Scopolamine—Pain—Docetaxel—ovarian cancer	0.000326	0.0023	CcSEcCtD
Scopolamine—Constipation—Docetaxel—ovarian cancer	0.000326	0.0023	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—ovarian cancer	0.000324	0.00228	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—ovarian cancer	0.000323	0.00228	CcSEcCtD
Scopolamine—Asthenia—Paclitaxel—ovarian cancer	0.000323	0.00228	CcSEcCtD
Scopolamine—Pruritus—Paclitaxel—ovarian cancer	0.000319	0.00224	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—ovarian cancer	0.000317	0.00224	CcSEcCtD
Scopolamine—Erythema—Epirubicin—ovarian cancer	0.000315	0.00222	CcSEcCtD
Scopolamine—Feeling abnormal—Docetaxel—ovarian cancer	0.000315	0.00221	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—ovarian cancer	0.000313	0.00221	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—ovarian cancer	0.000311	0.00219	CcSEcCtD
Scopolamine—Body temperature increased—Docetaxel—ovarian cancer	0.000302	0.00212	CcSEcCtD
Scopolamine—Abdominal pain—Docetaxel—ovarian cancer	0.000302	0.00212	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—ovarian cancer	0.0003	0.00211	CcSEcCtD
Scopolamine—Dizziness—Paclitaxel—ovarian cancer	0.000298	0.0021	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—ovarian cancer	0.000297	0.00209	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—ovarian cancer	0.000294	0.00207	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—ovarian cancer	0.000292	0.00206	CcSEcCtD
Scopolamine—Agitation—Epirubicin—ovarian cancer	0.00029	0.00204	CcSEcCtD
Scopolamine—Vomiting—Paclitaxel—ovarian cancer	0.000286	0.00202	CcSEcCtD
Scopolamine—Rash—Paclitaxel—ovarian cancer	0.000284	0.002	CcSEcCtD
Scopolamine—Dermatitis—Paclitaxel—ovarian cancer	0.000284	0.002	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—ovarian cancer	0.000283	0.002	CcSEcCtD
Scopolamine—Headache—Paclitaxel—ovarian cancer	0.000282	0.00199	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—ovarian cancer	0.000275	0.00194	CcSEcCtD
Scopolamine—Asthenia—Docetaxel—ovarian cancer	0.000274	0.00193	CcSEcCtD
Scopolamine—Pruritus—Docetaxel—ovarian cancer	0.00027	0.0019	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—ovarian cancer	0.000268	0.00189	CcSEcCtD
Scopolamine—Nausea—Paclitaxel—ovarian cancer	0.000267	0.00188	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000267	0.00188	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—ovarian cancer	0.000263	0.00185	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—ovarian cancer	0.000262	0.00185	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—ovarian cancer	0.00026	0.00183	CcSEcCtD
Scopolamine—Oedema—Epirubicin—ovarian cancer	0.000257	0.00181	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—ovarian cancer	0.000252	0.00178	CcSEcCtD
Scopolamine—Dizziness—Docetaxel—ovarian cancer	0.000252	0.00178	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—ovarian cancer	0.000251	0.00177	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—ovarian cancer	0.00025	0.00176	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000249	0.00175	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000247	0.00174	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—ovarian cancer	0.000243	0.00171	CcSEcCtD
Scopolamine—Vomiting—Docetaxel—ovarian cancer	0.000243	0.00171	CcSEcCtD
Scopolamine—Rash—Docetaxel—ovarian cancer	0.000241	0.00169	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—ovarian cancer	0.000241	0.00169	CcSEcCtD
Scopolamine—Dermatitis—Docetaxel—ovarian cancer	0.00024	0.00169	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—ovarian cancer	0.00024	0.00169	CcSEcCtD
Scopolamine—Headache—Docetaxel—ovarian cancer	0.000239	0.00168	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—ovarian cancer	0.000238	0.00168	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000234	0.00164	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—ovarian cancer	0.000232	0.00164	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—ovarian cancer	0.000231	0.00163	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00023	0.00162	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—ovarian cancer	0.000229	0.00161	CcSEcCtD
Scopolamine—Nausea—Docetaxel—ovarian cancer	0.000227	0.0016	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—ovarian cancer	0.000223	0.00157	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—ovarian cancer	0.000222	0.00156	CcSEcCtD
Scopolamine—Pain—Epirubicin—ovarian cancer	0.00022	0.00155	CcSEcCtD
Scopolamine—Constipation—Epirubicin—ovarian cancer	0.00022	0.00155	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—ovarian cancer	0.000212	0.00149	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—ovarian cancer	0.000212	0.00149	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—ovarian cancer	0.000205	0.00145	CcSEcCtD
Scopolamine—Pain—Doxorubicin—ovarian cancer	0.000204	0.00143	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—ovarian cancer	0.000204	0.00143	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—ovarian cancer	0.000203	0.00143	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—ovarian cancer	0.000203	0.00143	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000196	0.00138	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—ovarian cancer	0.000188	0.00133	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—ovarian cancer	0.000188	0.00133	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—ovarian cancer	0.000185	0.0013	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—ovarian cancer	0.000182	0.00128	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—ovarian cancer	0.000171	0.0012	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—ovarian cancer	0.00017	0.0012	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—ovarian cancer	0.000169	0.00119	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—ovarian cancer	0.000164	0.00115	CcSEcCtD
Scopolamine—Rash—Epirubicin—ovarian cancer	0.000162	0.00114	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—ovarian cancer	0.000162	0.00114	CcSEcCtD
Scopolamine—Headache—Epirubicin—ovarian cancer	0.000161	0.00114	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—ovarian cancer	0.000158	0.00111	CcSEcCtD
Scopolamine—Nausea—Epirubicin—ovarian cancer	0.000153	0.00108	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—ovarian cancer	0.000151	0.00107	CcSEcCtD
Scopolamine—Rash—Doxorubicin—ovarian cancer	0.00015	0.00106	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—ovarian cancer	0.00015	0.00106	CcSEcCtD
Scopolamine—Headache—Doxorubicin—ovarian cancer	0.000149	0.00105	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—ovarian cancer	0.000141	0.000996	CcSEcCtD
